Live Breaking News & Updates on Diffuse Scleroderma

Stay updated with breaking news from Diffuse scleroderma. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

EULAR SSc Recommendations Now Include Immunosuppressants

The update to 2017 recommendations include targeted synthetic and biologic disease-modifying antirheumatic drugs for the first time. ....

Ariane Herrick , European Alliance Of Associations , European Congress , University Of Manchester England , Boehringer Ingelheim , European Alliance , Del Galdo , Leeds Teaching Hospital , Scleroderma Trials , Crest Syndrome , Biologic Therapy , Pulmonary Hypertension , Systemic Sclerosis , Diffuse Scleroderma , Interstitial Lung Disease , Heart Failure , Lung Fibrosis , Pulmonary Fibrosis , Ibrosis Pulmonary , Monoclonal Antibody , Antineoplastic Drug , Nti Cancer Agents ,

Call It Preclinical or Subclinical, ILD in RA Needs to Be Tracked

Despite ILD being a leading cause of death in RA patients, there are no clinical guidelines for monitoring this lung condition in this population, experts say. ....

United States , New York , Mayo Clinic In Rochester , Hospital For Special Surgery , Elizabethr Volkmann , Los Angeles , Jessicak Gordon , Johnm Davis , Program At University Of California , National Jewish Health In Denver , Connective Tissue Disease , Related Interstitial Lung Disease , Medscape Medical , Lancet Rheumatology , Mayo Clinic , Special Surgery , New York City , Future Research , National Jewish Health , Rheumatoid Arthritis , Interstitial Lung Disease , Oint Inflammation , Preventive Screening , Nt Ears , Clinical Guidelines , Computed Tomography ,

CV Risk Score Multipliers Suggested for Rheumatic Diseases

Guidelines could tailor cardiovascular risk scores by using a multiplier of 2.5 for systemic sclerosis, 2.0 for lupus, and 1.5 for any other rheumatic disease. ....

Nathalie Conrad , Iain Mcinnes , European Union Horizon , University Of Glasgow , European Society For Cardiology , European Alliance Of Associations , Oxford University Innovation , Catholic University Leuven Belgium , Uk Clinical Practice Research Datalink , Research Foundation Flounders , Practice Research Datalink , Catholic University Leuven , Rheumatic Diseases , European Alliance , European Union , European Society , Belgian Based Research Foundation , Oxford University , Heart Failure , Cardiovascular Disease , Vd Cardiovascular Disease , Rheumatic Disease , Systemic Lupus Erythematosus , Autoimmune Disease , Atrial Fibrillation , F Atrial Fibrillation ,

Hormones' Impact Described in Transgender Rheumatology Patients

Gender-affirming hormone therapy does not need to be a strict contraindication in transgender patients with rheumatic disease, an author of a new case series and systematic review said. ....

Johns Hopkins University , United States , Vagishwari Murugesan , Kristen Mathias , University Of Toronto , University Of Southern California Medical Center , Lancet Summit , Los Angeles County , Southern California Medical Center , Could Pave Way , Larger Studies , Systemic Lupus Erythematosus , Social Issues , Rheumatic Disease , Rheumatoid Arthritis , Systemic Sclerosis , Diffuse Scleroderma , Endocrine Therapy , Hormone Therapy , Autoimmune Disease , Physician Patient Decision Making , Patient Counseling , Rovider Patient Communication ,

New Blood Tests Approved for Lupus, Systemic Sclerosis Diagnoses

The Food and Drug Administration has approved a new diagnostic blood test to detect monospecific Ribosomal P antibodies to support a diagnosis of systemic lupus erythematosus. ....

United States , Henry Homburger , Thermo Fisher Phadia Immunology Reference Laboratory , Thermo Fisher Scientific Inc , Drug Administration , Thermo Fisher Scientific , Elia Rib P , Professor Emeritus , Laboratory Medicine , Mayo Clinic College , Systemic Lupus Erythematosus , Systemic Sclerosis , Diffuse Scleroderma , Us Food And Drug Administration , Nited States Food And Drug Administration , Crest Syndrome , Iological Marker ,